Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001949846-25-000393
Filing Date
2025-08-20
Accepted
2025-08-20 10:26:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5546
  Complete submission text file 0001949846-25-000393.txt   6970
Mailing Address C/O WATSON PHARMA INC 360 MOUNT KEMBLE AVE MORRISTOWN NJ 07960
Business Address
BOYER ANDREW S (Reporting) CIK: 0001239546 (see all company filings)

 

Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38485 | Film No.: 251234546
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)